2. Balaban CD, Jacob RG, Furman JM. 2011; Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 11:379–94. DOI:
10.1586/ern.11.19. PMID:
21375443. PMCID:
PMC3107725.
Article
4. Hadjikhani N, Ward N, Boshyan J, Napadow V, Maeda Y, Truini A, et al. 2013; The missing link: enhanced functional connectivity between amygdala and visceroceptive cortex in migraine. Cephalalgia. 33:1264–8. DOI:
10.1177/0333102413490344. PMID:
23720503. PMCID:
PMC3797870.
Article
7. de Tommaso M, Libro G, Guido M, Difruscolo O, Losito L, Sardaro M, et al. 2004; Nitroglycerin induces migraine headache and central sensitization phenomena in patients with migraine without aura: a study of laser evoked potentials. Neurosci Lett. 363:272–5. DOI:
10.1016/j.neulet.2004.04.029. PMID:
15182958.
Article
9. Flores Á, Herry C, Maldonado R, Berrendero F. 2017; Facilitation of contextual fear extinction by orexin-1 receptor antagonism is associated with the activation of specific amygdala cell subpopulations. Int J Neuropsychopharmacol. 20:654–9. DOI:
10.1093/ijnp/pyx029. PMID:
28453642. PMCID:
PMC5570099.
Article
10. Kim TK, Han PL. 2016; Functional connectivity of basolateral amygdala neurons carrying orexin receptors and melanin-concentrating hormone receptors in regulating sociability and mood-related behaviors. Exp Neurobiol. 25:307–17. DOI:
10.5607/en.2016.25.6.307. PMID:
28035181. PMCID:
PMC5195816.
Article
11. Holland PR, Akerman S, Goadsby PJ. 2006; Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci. 24:2825–33. DOI:
10.1111/j.1460-9568.2006.05168.x. PMID:
17156207.
Article
13. Kooshki R, Abbasnejad M, Esmaeili-Mahani S, Raoof M, Sheibani V. 2020; Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats. Neuropharmacology. 178:107981. DOI:
10.1016/j.neuropharm.2020.107981. PMID:
32745488.
Article
14. Raoof M, Shakoori A, Kooshki R, Abbasnejad M, Amanpour S. 2017; The effects of regular exercise on capsaicin-induced pulpal pain and pain-induced changes in passive avoidance learning and memory in rats. Korean J Pain. 30:258–64. DOI:
10.3344/kjp.2017.30.4.258. PMID:
29123620. PMCID:
PMC5665737.
Article
17. Farkas S, Bölcskei K, Markovics A, Varga A, Kis-Varga Á, Kormos V, et al. 2016; Utility of different outcome measures for the nitroglycerin model of migraine in mice. J Pharmacol Toxicol Methods. 77:33–44. DOI:
10.1016/j.vascn.2015.09.006. PMID:
26456070.
Article
19. Greco R, Demartini C, Zanaboni AM, Tassorelli C. 2018; Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing. J Headache Pain. 19:51. DOI:
10.1186/s10194-018-0879-6. PMID:
30003352. PMCID:
PMC6043463.
Article
20. Li Y, Zhang Q, Qi D, Zhang L, Yi L, Li Q, et al. 2016; Valproate ameliorates nitroglycerin-induced migraine in trigeminal nucleus caudalis in rats through inhibition of NF-κB. J Headache Pain. 17:49. DOI:
10.1186/s10194-016-0631-z. PMID:
27150105. PMCID:
PMC4859223.
Article
24. Schwedt TJ, Krauss MJ, Frey K, Gereau RW 4th. 2011; Episodic and chronic migraineurs are hypersensitive to thermal stimuli between migraine attacks. Cephalalgia. 31:6–12. DOI:
10.1177/0333102410365108. PMID:
20974609. PMCID:
PMC3541827.
Article
25. Gottschalk MG, Richter J, Ziegler C, Schiele MA, Mann J, Geiger MJ, et al. 2019; Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes. Transl Psychiatry. 9:75. DOI:
10.1038/s41398-019-0415-8. PMID:
30718541. PMCID:
PMC6361931.
Article
27. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, et al. 2010; A key role for orexin in panic anxiety. Nat Med. 16:111–5. DOI:
10.1038/nm.2075. PMID:
20037593. PMCID:
PMC2832844.
Article
28. Flores Á, Valls-Comamala V, Costa G, Saravia R, Maldonado R, Berrendero F. 2014; The hypocretin/orexin system mediates the extinction of fear memories. Neuropsychopharmacology. 39:2732–41. DOI:
10.1038/npp.2014.146. PMID:
24930888. PMCID:
PMC4200503.
Article
29. Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, et al. 2018; The orexin/receptor system: molecular mechanism and therapeutic potential for neurological diseases. Front Mol Neurosci. 11:220. DOI:
10.3389/fnmol.2018.00220. PMID:
30002617. PMCID:
PMC6031739.
Article
30. Schafe GE, Atkins CM, Swank MW, Bauer EP, Sweatt JD, LeDoux JE. 2000; Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J Neurosci. 20:8177–87. DOI:
10.1523/JNEUROSCI.20-21-08177.2000. PMID:
11050141. PMCID:
PMC6772720.
Article
31. Keil MF, Briassoulis G, Stratakis CA. 2016; The role of protein kinase A in anxiety behaviors. Neuroendocrinology. 103:625–39. DOI:
10.1159/000444880. PMID:
26939049.
Article
33. Di Benedetto B, Kallnik M, Weisenhorn DM, Falls WA, Wurst W, Hölter SM. 2009; Activation of ERK/MAPK in the lateral amygdala of the mouse is required for acquisition of a fear-potentiated startle response. Neuropsychopharmacology. 34:356–66. DOI:
10.1038/npp.2008.57. PMID:
18432190.
Article
34. Maldonado NM, Espejo PJ, Martijena ID, Molina VA. 2014; Activation of ERK2 in basolateral amygdala underlies the promoting influence of stress on fear memory and anxiety: influence of midazolam pretreatment. Eur Neuropsychopharmacol. 24:262–70. DOI:
10.1016/j.euroneuro.2013.10.005. PMID:
24182621.
Article
35. Abbas MG, Shoji H, Soya S, Hondo M, Miyakawa T, Sakurai T. 2015; Comprehensive behavioral analysis of male Ox1r (-/-) mice showed implication of orexin receptor-1 in mood, anxiety, and social behavior. Front Behav Neurosci. 9:324. DOI:
10.3389/fnbeh.2015.00324. PMID:
26696848. PMCID:
PMC4674555.
36. Yang L, Zou B, Xiong X, Pascual C, Xie J, Malik A, et al. 2013; Hypocretin/orexin neurons contribute to hippocampus-dependent social memory and synaptic plasticity in mice. J Neurosci. 33:5275–84. DOI:
10.1523/JNEUROSCI.3200-12.2013. PMID:
23516292. PMCID:
PMC3640412.
Article
37. Blouin AM, Fried I, Wilson CL, Staba RJ, Behnke EJ, Lam HA, et al. 2013; Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat Commun. 4:1547. DOI:
10.1038/ncomms2461. PMID:
23462990. PMCID:
PMC3595130.
Article
38. Eacret D, Grafe LA, Dobkin J, Gotter AL, Renger JJ, Winrow CJ, et al. 2019; Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory. Behav Brain Res. 356:444–52. DOI:
10.1016/j.bbr.2018.05.032. PMID:
29902478.
Article
40. Flanigan ME, Aleyasin H, Li L, Burnett CJ, Chan KL, LeClair KB, et al. 2020; Orexin signaling in GABAergic lateral habenula neurons modulates aggressive behavior. Nat Neurosci. 23:638–50. DOI:
10.1038/s41593-020-0617-7. PMID:
32284606. PMCID:
PMC7195257.
Article
41. Ward RJ, Pediani JD, Milligan G. 2011; Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A. J Biol Chem. 286:37414–28. DOI:
10.1074/jbc.M111.287649. PMID:
21908614. PMCID:
PMC3199489.
Article
42. Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. 2015; Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex. 25:1330–47. DOI:
10.1093/cercor/bht326. PMID:
24297328. PMCID:
PMC4397574.
Article
45. Kosarmadar N, Ghasemzadeh Z, Rezayof A. 2015; Inhibition of microglia in the basolateral amygdala enhanced morphine-induced antinociception: possible role of GABAA receptors. Eur J Pharmacol. 765:157–63. DOI:
10.1016/j.ejphar.2015.08.027. PMID:
26297974.
Article
46. Pavlovic JM, Akcali D, Bolay H, Bernstein C, Maleki N. 2017; Sex-related influences in migraine. J Neurosci Res. 95:587–93. DOI:
10.1002/jnr.23903. PMID:
27870430.
48. Maleki N. Maassen van den Brink A, MacGregor EA, editors. 2019. Gender differences in imaging studies in migraine. Gender and migraine. Springer;Cham: p. 101–11.
Article